Cme Group EPS History: Annual & Quarterly (CME)
Cme Group's diluted EPS was $11.16 for fiscal 2025.
View full Cme Group company overviewCme Group annual diluted eps history
| Fiscal year | Period ended | Diluted EPS | Basic EPS | Change | Growth |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.16 | $11.18 | $1.49 | +15.41% |
| 2024 | 2024-12-31 | $9.67 | $9.69 | $0.81 | +9.14% |
| 2023 | 2023-12-31 | $8.86 | $8.87 | $1.46 | +19.73% |
| 2022 | 2022-12-31 | $7.40 | $7.41 | $0.11 | +1.51% |
| 2021 | 2021-12-31 | $7.29 | $7.30 | $1.42 | +24.19% |
| 2020 | 2020-12-31 | $5.87 | $5.88 | -$0.04 | −0.68% |
| 2019 | 2019-12-31 | $5.91 | $5.93 | $0.20 | +3.50% |
| 2018 | 2018-12-31 | $5.71 | $5.73 | -$6.23 | −52.18% |
| 2017 | 2017-12-31 | $11.94 | $12.00 | $7.41 | +163.58% |
| 2016 | 2016-12-31 | $4.53 | $4.55 | $0.84 | +22.76% |
| 2015 | 2015-12-31 | $3.69 | $3.71 | $0.34 | +10.15% |
| 2014 | 2014-12-31 | $3.35 | $3.37 | $0.43 | +14.73% |
| 2013 | 2013-12-31 | $2.92 | $2.94 | $0.22 | +8.15% |
| 2012 | 2012-12-31 | $2.70 | $2.71 | -$2.73 | −50.28% |
| 2011 | 2011-12-31 | $5.43 | $5.45 | $2.57 | +89.86% |
| 2010 | 2010-12-31 | $2.86 | $2.87 | -$9.55 | −76.95% |
| 2009 | 2009-12-31 | $12.41 | $12.44 | $0.28 | +2.31% |
| 2008 | 2008-12-31 | $12.13 | $12.18 | -$2.80 | −18.75% |
| 2007 | 2007-12-31 | $14.93 | $15.05 | — | — |
Cme Group quarterly diluted eps
| Fiscal quarter | Period ended | Diluted EPS | Basic EPS | Change | YoY change |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.88 | $2.89 | $0.07 | +2.49% |
| Q1 2026 | 2026-03-31 | $3.18 | $3.25 | $0.56 | +21.37% |
| Q4 2025 | 2025-12-31 | $3.24 | $3.25 | — | — |
| Q3 2025 | 2025-09-30 | $2.49 | $2.49 | -$0.01 | −0.40% |
| Q2 2025 | 2025-06-30 | $2.81 | $2.81 | $0.39 | +16.12% |
| Q1 2025 | 2025-03-31 | $2.62 | $2.63 | $0.27 | +11.49% |
| Q3 2024 | 2024-09-30 | $2.50 | $2.51 | $0.44 | +21.36% |
| Q2 2024 | 2024-06-30 | $2.42 | $2.43 | $0.28 | +13.08% |
| Q1 2024 | 2024-03-31 | $2.35 | $2.35 | -$0.08 | −3.29% |
| Q3 2023 | 2023-09-30 | $2.06 | $2.06 | $0.19 | +10.16% |
| Q2 2023 | 2023-06-30 | $2.14 | $2.14 | $0.32 | +17.58% |
| Q1 2023 | 2023-03-31 | $2.43 | $2.43 | $0.48 | +24.62% |
| Q3 2022 | 2022-09-30 | $1.87 | $1.87 | -$0.71 | −27.52% |
| Q2 2022 | 2022-06-30 | $1.82 | $1.82 | $0.40 | +28.17% |
| Q1 2022 | 2022-03-31 | $1.95 | $1.96 | $0.35 | +21.87% |
| Q3 2021 | 2021-09-30 | $2.58 | $2.59 | $1.43 | +124.35% |
| Q2 2021 | 2021-06-30 | $1.42 | $1.42 | $0.02 | +1.43% |
| Q1 2021 | 2021-03-31 | $1.60 | $1.60 | -$0.54 | −25.23% |
| Q4 2020 | 2020-12-31 | $1.18 | $1.18 | -$0.13 | −9.92% |
| Q3 2020 | 2020-09-30 | $1.15 | $1.15 | -$0.63 | −35.39% |
| Q2 2020 | 2020-06-30 | $1.40 | $1.41 | -$0.03 | −2.10% |
| Q1 2020 | 2020-03-31 | $2.14 | $2.14 | $0.75 | +53.96% |
| Q4 2019 | 2019-12-31 | $1.31 | $1.31 | $0.22 | +20.18% |
| Q3 2019 | 2019-09-30 | $1.78 | $1.78 | $0.57 | +47.11% |
| Q2 2019 | 2019-06-30 | $1.43 | $1.44 | -$0.23 | −13.86% |
| Q1 2019 | 2019-03-31 | $1.39 | $1.39 | -$0.37 | −21.02% |
| Q4 2018 | 2018-12-31 | $1.09 | $1.10 | -$7.54 | −87.37% |
| Q3 2018 | 2018-09-30 | $1.21 | $1.21 | $0.30 | +32.97% |
| Q2 2018 | 2018-06-30 | $1.66 | $1.67 | $0.44 | +36.07% |
| Q1 2018 | 2018-03-31 | $1.76 | $1.76 | $0.58 | +49.15% |
| Q4 2017 | 2017-12-31 | $8.63 | $8.67 | $7.53 | +684.55% |
| Q3 2017 | 2017-09-30 | $0.91 | $0.91 | -$0.48 | −34.53% |
| Q2 2017 | 2017-06-30 | $1.22 | $1.23 | $0.27 | +28.42% |
| Q1 2017 | 2017-03-31 | $1.18 | $1.18 | $0.09 | +8.26% |
| Q4 2016 | 2016-12-31 | $1.10 | $1.10 | $0.24 | +27.91% |
| Q3 2016 | 2016-09-30 | $1.39 | $1.40 | $0.33 | +31.13% |
| Q2 2016 | 2016-06-30 | $0.95 | $0.95 | $0.17 | +21.79% |
| Q1 2016 | 2016-03-31 | $1.09 | $1.09 | $0.11 | +11.22% |
| Q4 2015 | 2015-12-31 | $0.86 | $0.87 | -$0.05 | −5.49% |
| Q3 2015 | 2015-09-30 | $1.06 | $1.07 | $0.20 | +23.26% |
| Q2 2015 | 2015-06-30 | $0.78 | $0.79 | -$0.01 | −1.27% |
| Q1 2015 | 2015-03-31 | $0.98 | $0.98 | $0.19 | +24.05% |
| Q4 2014 | 2014-12-31 | $0.91 | $0.91 | $0.33 | +56.90% |
| Q3 2014 | 2014-09-30 | $0.86 | $0.87 | $0.15 | +21.13% |
| Q2 2014 | 2014-06-30 | $0.79 | $0.79 | -$0.14 | −15.05% |
| Q1 2014 | 2014-03-31 | $0.79 | $0.80 | $0.08 | +11.27% |
| Q4 2013 | 2013-12-31 | $0.58 | $0.58 | $0.08 | +16.00% |
| Q3 2013 | 2013-09-30 | $0.71 | $0.71 | $0.05 | +7.58% |
| Q2 2013 | 2013-06-30 | $0.93 | $0.94 | $0.19 | +25.68% |
| Q1 2013 | 2013-03-31 | $0.71 | $0.71 | -$0.09 | −11.25% |
| Q4 2012 | 2012-12-31 | $0.50 | $0.50 | -$1.75 | −77.78% |
| Q3 2012 | 2012-09-30 | $0.66 | $0.66 | -$0.29 | −30.53% |
| Q2 2012 | 2012-06-30 | $0.74 | $0.74 | -$0.14 | −15.91% |
| Q1 2012 | 2012-03-31 | $0.80 | $0.81 | -$0.56 | −41.18% |
| Q4 2011 | 2011-12-31 | $2.25 | $2.26 | -$0.68 | −23.21% |
| Q3 2011 | 2011-09-30 | $0.95 | $0.95 | -$2.71 | −74.04% |
| Q2 2011 | 2011-06-30 | $0.88 | $0.88 | -$3.23 | −78.59% |
| Q1 2011 | 2011-03-31 | $1.36 | $1.37 | -$2.26 | −62.43% |
| Q4 2010 | 2010-12-31 | $2.93 | $2.94 | -$0.11 | −3.62% |
| Q3 2010 | 2010-09-30 | $3.66 | $3.67 | $0.62 | +20.39% |
| Q2 2010 | 2010-06-30 | $4.11 | $4.13 | $0.78 | +23.42% |
| Q1 2010 | 2010-03-31 | $3.62 | $3.63 | $0.62 | +20.67% |
| Q4 2009 | 2009-12-31 | $3.04 | $3.05 | — | — |
| Q3 2009 | 2009-09-30 | $3.04 | $3.05 | $0.23 | +8.19% |
| Q2 2009 | 2009-06-30 | $3.33 | $3.34 | -$0.34 | −9.26% |
| Q1 2009 | 2009-03-31 | $3.00 | $3.00 | — | — |
| Q3 2008 | 2008-09-30 | $2.81 | $2.82 | — | — |
| Q2 2008 | 2008-06-30 | $3.67 | $3.69 | — | — |
Cme Group diluted eps trends
Over the last five fiscal years, Cme Group's diluted eps increased from $5.87 to $11.16, a change of $5.29. The latest reported quarter, Q2 2026, shows $2.88.
What earnings per share (EPS) means
Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.
SEC-reported diluted and basic EPS
TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...